Your browser is no longer supported. Please, upgrade your browser.
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-3.58 Insider Own1.05% Shs Outstand1.10B Perf Week-4.72%
Market Cap10.62B Forward P/E3.53 EPS next Y2.74 Insider Trans-1.44% Shs Float1.09B Perf Month8.16%
Income-3915.00M PEG- EPS next Q0.65 Inst Own51.10% Short Float1.80% Perf Quarter15.51%
Sales16.32B P/S0.65 EPS this Y-297.90% Inst Trans-0.03% Short Ratio2.31 Perf Half Y-5.84%
Book/sh9.36 P/B1.03 EPS next Y5.14% ROA-7.90% Target Price11.47 Perf Year3.97%
Cash/sh2.22 P/C4.36 EPS next 5Y4.80% ROE-39.20% 52W Range8.24 - 13.30 Perf YTD0.31%
Dividend- P/FCF- EPS past 5Y-32.00% ROI-9.50% 52W High-27.22% Beta1.37
Dividend %- Quick Ratio0.70 Sales past 5Y-3.30% Gross Margin47.60% 52W Low17.48% ATR0.29
Employees39717 Current Ratio1.00 Sales Q/Q1.00% Oper. Margin-17.90% RSI (14)52.02 Volatility2.59% 3.21%
OptionableYes Debt/Eq2.43 EPS Q/Q46.70% Profit Margin-24.00% Rel Volume0.49 Prev Close9.70
ShortableYes LT Debt/Eq2.09 EarningsOct 27 BMO Payout- Avg Volume8.50M Price9.68
Recom2.80 SMA201.70% SMA501.83% SMA200-7.08% Volume4,202,320 Change-0.21%
May-04-21Downgrade UBS Buy → Neutral $15 → $11
Apr-07-21Resumed RBC Capital Mkts Sector Perform $11
Nov-25-20Initiated Oppenheimer Perform
Aug-06-20Upgrade Barclays Underweight → Equal Weight $10 → $13
Jul-27-20Resumed Goldman Neutral $12
Jun-01-20Upgrade SunTrust Hold → Buy
Apr-24-20Resumed Citigroup Neutral $10
Apr-06-20Upgrade UBS Neutral → Buy $14 → $12
Feb-24-20Downgrade Edward Jones Hold → Sell
Nov-12-19Upgrade JP Morgan Underweight → Neutral $8
Oct-17-19Upgrade Gabelli & Co Hold → Buy
Aug-07-19Downgrade Evercore ISI Outperform → In-line
Jul-19-19Initiated Wolfe Research Peer Perform
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-10-19Resumed Credit Suisse Neutral
Jul-05-19Upgrade Argus Hold → Buy
Jun-11-19Initiated Barclays Underweight $8
Jun-03-19Upgrade Oppenheimer Perform → Outperform $12
May-30-19Downgrade BofA/Merrill Buy → Underperform
May-28-19Downgrade UBS Buy → Neutral
Oct-13-21 02:00AM  
Oct-08-21 06:06AM  
Oct-04-21 12:24PM  
11:05AM  
10:28AM  
08:27AM  
07:56AM  
06:18AM  
02:00AM  
Oct-01-21 10:20AM  
Sep-30-21 08:00AM  
07:30AM  
Sep-28-21 04:34PM  
12:40PM  
Sep-20-21 04:14PM  
Sep-17-21 05:05AM  
Sep-11-21 06:05AM  
Sep-08-21 08:00AM  
05:51AM  
Sep-01-21 11:23AM  
Aug-31-21 04:15PM  
Aug-30-21 08:00AM  
Aug-20-21 08:00AM  
Aug-17-21 01:56PM  
Jul-29-21 10:50AM  
Jul-28-21 11:32PM  
03:43PM  
08:18AM  
08:07AM  
07:44AM  
07:34AM  
07:30AM  
07:02AM  
07:00AM  
Jul-23-21 05:51AM  
Jul-21-21 08:00AM  
06:07AM  
06:00AM  
Jul-20-21 10:49AM  
Jul-02-21 11:46AM  
Jul-01-21 12:14PM  
Jun-29-21 03:24PM  
06:00AM  
Jun-28-21 08:00AM  
Jun-26-21 06:06AM  
Jun-23-21 08:12AM  
Jun-22-21 05:18PM  
02:30AM  
Jun-21-21 09:47AM  
08:01AM  
08:01AM  
Jun-17-21 06:00AM  
06:00AM  
Jun-16-21 08:00PM  
07:36AM  
Jun-14-21 08:15AM  
Jun-11-21 02:06AM  
Jun-09-21 06:06AM  
Jun-08-21 05:30AM  
Jun-03-21 08:15AM  
08:00AM  
May-20-21 09:34AM  
May-17-21 01:03PM  
08:00AM  
May-15-21 06:36AM  
May-10-21 08:00AM  
May-07-21 03:05PM  
06:31AM  
May-05-21 08:00AM  
May-04-21 11:14AM  
May-03-21 08:00AM  
Apr-29-21 04:18PM  
07:05AM  
Apr-28-21 04:26PM  
02:30PM  
02:29PM  
12:11PM  
10:55AM  
10:47AM  
10:10AM  
08:07AM  
07:40AM  
07:29AM  
07:00AM  
06:15AM  
Apr-27-21 08:00PM  
08:00AM  
Apr-23-21 11:09AM  
Apr-20-21 10:13AM  
Apr-19-21 08:00AM  
Apr-16-21 12:58PM  
Apr-15-21 08:00AM  
Apr-13-21 06:09AM  
Apr-08-21 07:54AM  
07:30AM  
03:00AM  
Apr-06-21 09:42AM  
09:28AM  
07:30AM  
Mar-26-21 05:51AM  
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fridriksdottir HafrunExecutive VP, Global R&DAug 10Sale9.9550,860506,02141,412Aug 12 04:04 PM
Drape EricExecutive VP Global OperationsMay 21Sale11.0140,000440,32033,128May 25 08:41 AM
Stark David MatthewExec. VP Chief Legal OfficerMay 11Sale10.2237,884387,1252,974May 13 07:48 AM
Fridriksdottir HafrunExecutive VP, Global R&DMay 11Sale10.2219,066194,83092,272May 13 07:45 AM
Drape EricExecutive VP Global OperationsMay 11Sale10.2219,804202,41373,128May 13 07:44 AM
Sabag MarkSee "Remarks" belowMar 16Sale11.22127,2441,427,61420,598Mar 17 04:03 PM
O'Grady Brendan P.EVP, North America CommercialMar 05Sale10.5411,436120,58014,868Mar 08 04:09 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 04Sale10.576,01263,52377,976Mar 08 04:03 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 04Sale10.5713,930147,1862,974Mar 08 04:12 PM
O'Grady Brendan P.EVP, North America CommercialMar 04Sale10.598,17286,51114,868Mar 08 04:09 PM
Nazzi GianfrancoEVP, International MarketsMar 04Sale10.5812,935136,9090Mar 08 04:08 PM
Fridriksdottir HafrunExecutive VP, Global R&DMar 04Sale10.579,515100,53673,454Mar 08 04:07 PM
Drape EricExecutive VP Global OperationsMar 04Sale10.586,18365,44355,048Mar 08 04:04 PM
Daniell RichardExec. VP, European CommercialMar 04Sale10.587,51379,52120,280Mar 08 04:02 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 03Sale10.866066,58370,058Mar 04 04:02 PM
Daniell RichardExec. VP, European CommercialMar 03Sale10.8899310,80311,873Mar 04 04:01 PM
Nazzi GianfrancoEVP, International MarketsMar 03Sale10.881,40015,2310Mar 04 04:04 PM
O'Grady Brendan P.EVP, North America CommercialMar 03Sale10.864635,02915,571Mar 04 04:05 PM
O'Grady Brendan P.EVP, North America CommercialMar 02Sale10.8515,085163,60114,868Mar 04 04:05 PM
Fridriksdottir HafrunExecutive VP, Global R&DMar 02Sale10.8250,000540,89064,064Mar 04 04:03 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 01Sale10.8318,430199,6122,974Mar 02 04:10 PM
Nazzi GianfrancoEVP, International MarketsMar 01Sale10.8775,587821,9250Mar 02 04:07 PM
O'Grady Brendan P.EVP, North America CommercialMar 01Sale10.9173,127798,02329,953Mar 02 04:07 PM
Fridriksdottir HafrunExecutive VP, Global R&DMar 01Sale10.8310,912118,186114,064Mar 02 04:05 PM
Drape EricExecutive VP Global OperationsMar 01Sale10.859,795106,28549,291Mar 02 04:04 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 01Sale10.837,48681,07969,264Mar 02 04:03 PM
Daniell RichardExec. VP, European CommercialMar 01Sale10.8520,598223,50710,765Mar 02 04:02 PM
Stark David MatthewExec. VP Chief Legal OfficerFeb 16Sale11.123,92643,6692,974Feb 17 04:09 PM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 16Sale11.122,09823,336103,294Feb 17 04:07 PM
Drape EricExecutive VP Global OperationsFeb 16Sale11.132,07923,13539,572Feb 17 04:06 PM
Stark David MatthewExec. VP Chief Legal OfficerFeb 09Sale12.6965,312829,1032,974Feb 11 04:12 PM
O'Grady Brendan P.EVP, North America CommercialFeb 09Sale12.6920,694262,70078,146Feb 11 04:08 PM
Nazzi GianfrancoEVP, International MarketsFeb 09Sale12.7221,635275,21760,410Feb 11 04:07 PM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 09Sale12.6929,496374,437100,037Feb 11 04:05 PM
Drape EricExecutive VP Global OperationsFeb 09Sale12.7217,979228,70937,725Feb 11 04:04 PM
Dethlefs SvenEVP Global Marketing&PortfolioFeb 09Sale12.6929,657376,48159,404Feb 11 04:03 PM
Daniell RichardExec. VP, European CommercialFeb 09Sale12.7268,422870,38910,765Feb 11 04:02 PM